Onorato, EM,
Alamanni, F,
Muratori, M,
Smolka, G,
Wojakowski, W,
Pysz, P,
Zorinas, A,
Zakarkaite, D,
Eltchaninoff, H,
Litzer, PY,
Godart, F,
Calvert, P,
Christou, C,
Mussayev, A,
Missiroli, B,
Buzaev, I,
Curello, S,
Tesorio, T,
Bartorelli, AL (2022) Between December 2014 and March 2021, 144
patients with aortic (Ao) or mitral (Mi) paravalvular
Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) The immune system is severely compromised in
patients with COVID-19. The representative group of 43
Zagidullin, N,
Ruslan, G,
Anton, T,
Paruir, D,
Sergey, D,
Irina, L,
Valentin, P (2022) SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN
PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA
Coronary Stent Thrombosis Prediction in
Patients With Acute Coronary Syndrome
not only in
patients at risk (with a history of inflammatory periodontal diseases), but also in other
Tyurin, Anton V.,
Akhiyarova, Karina E.,
Valishin, Damir A.,
Sadretdinova, Lidiya D.,
Khusainova, Leonora N.,
Zagidullin, Naufal S.,
Gantseva, Khalida K.,
Pavlov, Valentin N. (2022) The objective of our study was the analysis of using immunosuppressive therapy in
patientsXu, Dongxiao,
Zheng, Bingjie,
Wu, Qiaowei,
Yao, Jinbiao,
Ilyasova, Tatiana,
Beilerli, Aferinc,
Shi, Huaizhang (2022) and dural inversion synangiosis for the treatment of moyamoya disease in adults. Methods:
Patients treated
Zhang, G.,
Zhu, Y.,
Ling, Y.,
Chen, P.,
Dai, J.,
Wang, Ch.,
Xu, Sh.,
Shumadalova, A.,
Shi, H. (2022) strategy for
patients with AIS caused by PPCA remains unclear. We discuss our single-center experience
Gaponov, D.P.,
Khafizov, T.N.,
Kochkina, K.V.,
Chernov, I.I.,
Enginoev, S.T.,
Shaposhnikova, E.I. (2022) patients with aortic pathologies, for whom endovascular repair was performed: 51
patients (57%) with aortic